These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2999258)

  • 1. Uptake of [125I]iododeoxycytidine by cells infected with herpes simplex virus: a rapid screening test for resistance to acyclovir.
    Van Dyke RB; Connor JD
    J Infect Dis; 1985 Dec; 152(6):1206-11. PubMed ID: 2999258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates.
    Martin JL; Ellis MN; Keller PM; Biron KK; Lehrman SN; Barry DW; Furman PA
    Antimicrob Agents Chemother; 1985 Aug; 28(2):181-7. PubMed ID: 3010836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir.
    Collins P; Ellis MN
    J Med Virol; 1993; Suppl 1():58-66. PubMed ID: 8245894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
    Field HJ; Lay E
    Antiviral Res; 1984 Apr; 4(1-2):43-52. PubMed ID: 6331304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of thymidine kinase activities indiced in cells productively infected with herpesvirus saimiri and herpes simplex virus.
    Honess RW; O'Hare P; Young D
    J Gen Virol; 1982 Feb; 58(Pt 2):237-49. PubMed ID: 6278057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.
    Gaudreau A; Hill E; Balfour HH; Erice A; Boivin G
    J Infect Dis; 1998 Aug; 178(2):297-303. PubMed ID: 9697707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
    Tenser RB; Gaydos A; Hay KA
    J Virol; 1996 Feb; 70(2):1271-6. PubMed ID: 8551594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of herpes simplex virus type 1 isolates for acyclovir resistance using DiviTum® assay.
    Sauerbrei A; Vödisch S; Bohn K; Schacke M; Gronowitz S
    J Virol Methods; 2013 Mar; 188(1-2):70-2. PubMed ID: 23246510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytopathogenicity, drug susceptibility, and thymidine kinase activity of a retinovirulent herpes simplex virus type 2.
    Langford MP; Colacino JM; Kaiwar R; Mahjoub SB; Ganley JP
    J Med Virol; 1990 Aug; 31(4):301-5. PubMed ID: 2176674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of acyclovir-resistant and -sensitive clinical herpes simplex virus isolates from an immunocompromised patient.
    Christophers J; Sutton RN
    J Antimicrob Chemother; 1987 Sep; 20(3):389-98. PubMed ID: 2824424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey.
    Nugier F; Colin JN; Aymard M; Langlois M
    J Med Virol; 1992 Jan; 36(1):1-12. PubMed ID: 1315366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
    Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
    Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of [125I]deoxycytidine to detect herpes simplex virus-specific thymidine kinase in tissues of latently infected guinea pigs.
    Fong BS; Scriba M
    J Virol; 1980 Jun; 34(3):644-9. PubMed ID: 6247502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS.
    Gateley A; Gander RM; Johnson PC; Kit S; Otsuka H; Kohl S
    J Infect Dis; 1990 Apr; 161(4):711-5. PubMed ID: 2156946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.
    Sakuma S; Yamamoto M; Kumano Y; Mori R
    Arch Virol; 1988; 101(3-4):169-82. PubMed ID: 2845890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two methods in the determination of the sensitivity of 84 herpes simplex virus (HSV) type 1 and 2 clinical isolates to acyclovir and alpha-interferon.
    Brisebois JJ; Dumas VM; Joncas JH
    Antiviral Res; 1989 Mar; 11(2):67-75. PubMed ID: 2543287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine.
    Larsson A; Alenius S; Johansson NG; Oberg B
    Antiviral Res; 1983 Aug; 3(2):77-86. PubMed ID: 6312878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir.
    Collins P; Oliver NM
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():103-12. PubMed ID: 3025149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
    de Clercq E
    Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.